Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/07/24
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceGlobeNewsWire • 02/26/24
Is Alpha Tau Medical (DRTS) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 01/22/24
Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerGlobeNewsWire • 11/28/23
Down -20.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Alpha Tau Medical Ltd. (DRTS)Zacks Investment Research • 11/22/23
Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerGlobeNewsWire • 11/20/23
Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 11/16/23
Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilityGlobeNewsWire • 10/30/23
Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel's Hadassah Medical CenterGlobeNewsWire • 09/14/23
Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/28/23
Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRTGlobeNewsWire • 08/17/23
Alpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023GlobeNewsWire • 08/02/23
Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/23/23
Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge UniversityGlobeNewsWire • 05/17/23
Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network OpenGlobeNewsWire • 05/11/23
Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical TrialGlobeNewsWire • 04/03/23